Alyeska Investment Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Alyeska Investment Group’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-320,430	Closed	-$12.7M	–	682
2026 Q1	$12.7M	Buy	+320,430	New	+$8.2M	0.04%	373

Alyeska Investment Group's CNTA Position: Q2 2026 in Review

Alyeska Investment Group sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 320,430 shares — an estimated $12.7M sold.

Alyeska Investment Group first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $12.7M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Alyeska Investment Group reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Alyeska Investment Group sold 320,430 Centessa Pharmaceuticals shares in Q2 2026, an estimated $12.7M.
Alyeska Investment Group first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Alyeska Investment Group's Centessa Pharmaceuticals position peaked at $12.7M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.